Screening for Hepatitis B, C, and HIV among Drug Users
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan
This study is testing if having regular screening days for hepatitis B, C, and HIV can help drug users get better access to testing and treatment in a supportive environment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Limoges Academic / other |
| Locations | 1 site (Limoges, Haute Vienne) |
| Trial ID | NCT05361603 on ClinicalTrials.gov |
What this trial studies
This observational study aims to implement dedicated monthly screening days for viral hepatitis B, C, and HIV among drug users in non-conventional settings. Health professionals, including hepatologists and addiction specialists, will provide individualized care and management during these screening events. Patients will undergo various tests, including TRODs and FibroScan®, with results communicated confidentially. The study seeks to enhance access to screening and treatment for vulnerable populations.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and over who frequent unconventional care structures or are referred by healthcare professionals.
Not a fit: Patients who do not agree to participate in the research will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve early detection and management of viral hepatitis and HIV among drug users.
How similar studies have performed: Other studies have shown success in similar screening approaches, indicating potential for effective implementation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult 18 and over * Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector * Patient who agreed to participate to the research Exclusion Criteria: * Patient doesn't agree to participate to the research
Where this trial is running
Limoges, Haute Vienne
- Chu Limoges — Limoges, Haute Vienne, France (Recruiting)
Study contacts
- Principal investigator: Marilyne DEBETTE-GRATIEN, MD — Hôpital Dupuytren
- Study coordinator: Marilyne DEBETTE-GRATIEN, MD
- Email: MARILYNE.GRATIEN@chu-limoges.fr
- Phone: 33 5 55 05 87 26
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.